1. Home
  2. OCUL vs GBX Comparison

OCUL vs GBX Comparison

Compare OCUL & GBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • GBX
  • Stock Information
  • Founded
  • OCUL 2006
  • GBX 1974
  • Country
  • OCUL United States
  • GBX United States
  • Employees
  • OCUL N/A
  • GBX N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • GBX Railroads
  • Sector
  • OCUL Health Care
  • GBX Industrials
  • Exchange
  • OCUL Nasdaq
  • GBX Nasdaq
  • Market Cap
  • OCUL 1.4B
  • GBX 1.6B
  • IPO Year
  • OCUL 2014
  • GBX N/A
  • Fundamental
  • Price
  • OCUL $9.16
  • GBX $65.08
  • Analyst Decision
  • OCUL Strong Buy
  • GBX Hold
  • Analyst Count
  • OCUL 8
  • GBX 3
  • Target Price
  • OCUL $16.50
  • GBX $60.00
  • AVG Volume (30 Days)
  • OCUL 889.3K
  • GBX 399.1K
  • Earning Date
  • OCUL 11-14-2024
  • GBX 01-03-2025
  • Dividend Yield
  • OCUL N/A
  • GBX 1.84%
  • EPS Growth
  • OCUL N/A
  • GBX 163.31
  • EPS
  • OCUL N/A
  • GBX 4.96
  • Revenue
  • OCUL $61,442,000.00
  • GBX $3,544,700,000.00
  • Revenue This Year
  • OCUL $15.49
  • GBX $1.11
  • Revenue Next Year
  • OCUL $13.31
  • GBX N/A
  • P/E Ratio
  • OCUL N/A
  • GBX $13.12
  • Revenue Growth
  • OCUL 6.45
  • GBX N/A
  • 52 Week Low
  • OCUL $2.05
  • GBX $36.23
  • 52 Week High
  • OCUL $11.78
  • GBX $67.22
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 34.86
  • GBX 77.98
  • Support Level
  • OCUL $10.46
  • GBX $64.82
  • Resistance Level
  • OCUL $11.12
  • GBX $67.22
  • Average True Range (ATR)
  • OCUL 0.57
  • GBX 1.41
  • MACD
  • OCUL -0.22
  • GBX 0.24
  • Stochastic Oscillator
  • OCUL 0.60
  • GBX 93.67

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About GBX Greenbrier Companies Inc. (The)

Greenbrier Companies Inc designs, manufactures, and markets railroad freight car equipment in North America and Europe, marine barges in North America and provides wheel services, railcar refurbishment, and parts, leasing and other services to the railroad. Its segments include Manufacturing, Maintenance Services and Leasing & Management Services. The company generates a majority of its revenue from the manufacturing segment. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: